were Baht 45 million, an increase of 44% from 1Q2017, mainly from an increase in the Company’s credit balance accounts. 1.4 Gains and return on financial instruments The Company’s gains and return on

The Company reported Total revenues in 1Q19 of Baht 206.36 million, a 44.17% increase from 1Q18 revenues of baht 143.13 million. Net profit for 1Q19 increased by 103.09% to Baht 44.70 million from Baht

reported Total revenues in 2018 of Baht 654.29 million, a 20.95% increase from 2017. Net profit for 2018 increased by 39.82% to Baht 117.21 million from Baht 83.83 million in 2017, with Net profit margin at

reported Total revenues in 2019 of Thai Baht 911.00 million, a 39.23% increase from 2018 of Thai Baht 654.29. Net profit for 2019 increased by 36.76% to Thai Baht 160.30 million from Thai Baht 117.21 million

follows. Summary The Company reported Total revenues in 3Q19 of Baht 252.85 million, a 31.64% increase from 3Q18 revenues of Baht 192.08 million. Net profit for 3Q19 increased by 5.40% to Baht 47.95 million

follows. Summary The Company reported Total revenues in 3Q18 of Baht 192.08 million, a 19.90% increase from 3Q17 revenues of baht 160.20 million. Net profit for 3Q18 increased by 24.12% to Baht 45.49

1,330 million, an increase of 8 percent compared to the nine month period of the previous year, due to an improved performance of the Company’s wide range of investments. The Company’s gains and return on

 127.58 million or 16.42%  increase year‐over‐year  from THB 109.59 million  in  1Q19.   This represents an  increase  in  the cost of doctors, nurses, drugs, medical supplies and new  building

. Summary The Company reported Total revenues in 2Q19 of Baht 218.73 million, a 50.31% increase from 2Q18 revenues of baht 145.52 million. Net profit for 2Q19 increased by 72.14% to Baht 38.44 million from

% and decrease of 78%, compared to the same period of the previous year respectively. The Company would like to clarify the significant reasons for the increase/decrease in profits for the third quarter